The NIMH has recently funded a new R01 to study the computational, cognitive and neurobiological mechanisms underlying delusions in individuals with schizophrenia. Dr. Sheffield is the PI of the study with Co-I's Stephan Heckers, Aaron Brinen, Neil Woodward, Baxter Rogers, Jinyuan Liu and Philip Corlett (Yale School of Medicine). The grant will fund a 5-year clinical trial providing 16-weeks of psychotherapy for individuals with schizophrenia and strongly held paranoia.